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The role of age, gender and smoking on both
the genotoxic effects of Helicobacter pylori and
the efficacy of eradication therapy in a group
of patients with gastritis was investigated.
Gastritis was confirmed by endoscopy and
biopsy, and the presence of H. pylori by urease
testing. Pre- and post-treatment peripheral
blood lymphocyte cultures were prepared
from 17 patients and 25 metaphases per
patients were analysed for sister chromatid
exchange (SCE), a well-established technique
for the evaluation of human exposure to toxic
agents. Treatment with omeprazole,
clarithromycin and amoxycillin triple
therapy eradicated H. pylori in 94% of
patients and significantly reduced the SCE
frequency. Pre-treatment SCE frequency was
found to be positively correlated with age.
Female smokers tended to have higher post-
treatment SCE frequencies than male
smokers, and pre- and post-treatment SCE
frequencies were higher in older males than
in older females. Eradication therapy
decreased the genotoxicity of H. pylori, but
age in males and smoking in females may
decrease treatment efficacy.
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Introduction
Helicobacter pylori is a Gram-negative,
microaerophilic, spiral bacterium that infects
the gastric mucosa and plays an important role
in the aetiology of gastritis and peptic
ulceration in half of the world’s population.
Colonization of the host is assisted by factors
such as motility, urease production and
adhesion mechanisms. It damages the gastric
mucosa and induces inflammatory mediators
because of disease-inducing properties,
including the release of cytotoxins and urease.
In addition, its long-term persistence promotes
resistance to drug therapy, thereby increasing its
ulcerogenic and carcinogenic effects.1,2
Helicobacter pylori was recently designated a
carcinogen in humans by the International
Agency for Research on Cancer, sponsored by
the World Health Organization.3 – 5 There is a
strong relationship between H. pylori and gastric
cancer, although H. pylori is not directly
genotoxic or mutagenic. The carcinogenic
effects of H. pylori are a result of its properties.
For example, the abundant ammonia produced
as a result of the urease activity of the bacteria
may promote cell division, H. pylori
phospholipases may damage the epithelial cell
membrane, and CagA strains, which have
vacuolating cytotoxic activity, may impair the
defence capabilities of the host and sensitize the
epithelial cells to carcinogenesis.4
Sister chromatid exchange (SCE) analysis in
peripheral blood lymphocytes is a well-
established technique for the evaluation of
human exposure to toxic agents.6 This method
measures the interchanges of DNA between
replication products. Analysis by SCE is a very
sensitive method of assaying DNA damage and,
because many exchange-inducing agents are
mutagens, carcinogens, or both, this method is
used to test chemical agents with unknown
carcinogenic potentials.7
Helicobacter pylori infection can be cured with
antibiotics, and treating this infection can
potentially prevent cancer. At the time of
writing, however, there are no data to
demonstrate that H. pylori eradication modifies
an individual’s cancer risk.8
This study aimed to investigate whether the
risk of cancer is modified in patients with
gastritis by determining their SCE frequencies
before and after H. pylori eradication. The study
also considered whether age, gender and
smoking altered the effectiveness of the therapy. 
Patients and methods
PATIENTS
Patients with both gastritis and H. pylori
infection were enrolled in the study. Patients
were included if they were positive for H. pylori
by the urease test (CLO® test, Delta West,
Australia), and had gastritis confirmed by
histological examination of gastric biopsy
specimens, were not on any medication, had
not had gastric surgery, and had no symptoms
or history of other pathology or disease. Patients
gave verbal consent to participate in the study.
ANALYSIS AND TREATMENT
Age, gender and smoking habits were recorded.
Peripheral blood lymphocyte samples were
collected from the patients and cultured for
cytogenetic analysis. Patients self-administered
H. pylori triple therapy comprising omeprazole,
20-mg capsule, clarithromycin, 500-mg capsule,
and amoxycillin, 1-g capsule, twice daily for 
7 consecutive days. Seven days after the triple
therapy had been completed, endoscopy, the
urease test and gastric biopsy were repeated,
and blood samples collected for each patient. 
For cytogenetic (SCE) analysis of the pre- and
post-treatment blood samples, 0.3 ml of
peripheral blood was cultured in 5 ml
technetium-199 medium supplemented with
20% fetal calf serum, 1% L-glutamine, 
2.5% phytohaemagluttinin and penicillin–
streptomycin solution for 72 h. After 24 h, 
10 µg/ml 5-bromodeoxyuridine was added and
at the end of 72 h, routine harvest was
performed. The slides were kept for 7 days at
room temperature before staining for SCE with
0.3 M di-sodium hydrogen phosphate dihydrate
buffer solution with 2% Giemsa’s stain. The pH
of the solution was adjusted to 10.4 with
ammonia. For each patient, 25 metaphases
were scored.
STATISTICAL ANALYSIS
The Wilcoxon, partial correlation and
Pearson correlation tests were used to
analyse the results. P < 0.05 was considered
statistically significant.
Results
Seventeen patients took part in the study (seven
females and 10 males; age range, 14 – 53 years;
mean, 36.8 years), seven of whom were
smokers. None was receiving any other
medication. The age, gender, smoking habits,
and pre- and post-treatment SCE frequencies 
are shown in Table 1. H. pylori was eliminated 
in all but one patient (94%).
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Table 2 shows that the SCE frequency, a
measure of the damage and repair processes of
DNA, was significantly reduced after the triple
therapy in patients with gastritis (P < 0.01). The
mean SCE frequency decreased from 8.94 
to 5.84.
Patients whose pre-treatment SCE frequen-
cies were high tended to have higher post-
treatment SCE frequencies than patients whose
pre-treatment SCE values were low (r = –0.66; 
P < 0.01). Treatment effectiveness, as measured
by a decrease in the SCE frequency, was thus de-
pendent on the SCE frequency before treatment. 
There was a positive correlation between
age and pre-treatment SCE frequency 
(r = 0.59; P < 0.05) and, in men, increasing
age appeared to be associated with a
reduction in the effectiveness of the
treatment. In older patients, both the pre-
and post-treatment SCE frequencies of men
tended to be higher than in women. For
men, the analysis of age and pre-treatment
SCE frequencies gave values of r = 0.69 
and P < 0.05, and the analysis of age and
post-treatment SCE frequencies gave r = –0.85
and P < 0.01. 
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TABLE 1: 
Characteristics of patients with gastritis and Helicobacter pylori infection treated with
omeprazole, clarithromycin and amoxycillin: age, gender, pre- and post-treatment sister
chromatid exchange (SCE) frequencies, and smoking habits 
Pre-treatment Post-treatment Smoking 
Sex Age SCE frequencya SCE frequency status
F 39 7.36 7.12 NS  
M 33 10.16 6.24 S  
M 22 6.68 6.05 NS 
Mb 43 7.72 4.24 NS 
M 34 9.56 5.60 NS 
M 40 7.64 6.20 NS 
M 44 11.76 4.20 NS 
M 44 11.80 6.08 S 
M 23 5.44 6.68 S 
M 32 5.76 4.00 S 
F 14 8.48 5.40 NS 
F 42 11.00 4.80 S 
M 45 9.80 4.20 NS 
F 34 10.00 9.60 S 
F 50 10.20 5.00 S 
F 34 7.68 5.48 NS 
F 53 9.20 8.40 NS 
NS, non-smoker; S, smoker.
aThe number of SCEs in normal human cells ranges from 2 to 20 with a mean frequency of between 5 and 8.
bThis patient tested positive for H. pylori after treatment. 
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Female smokers tended to have higher
post-treatment SCE frequencies than male
smokers (r = –0.80; P < 0.05), and post-
treatment SCE frequencies were significantly
reduced both in the smokers and non-
smokers (P < 0.05, smoker group; P < 0.01,
non-smoker group; Table 2). A comparison
of the percentage variation in SCE
frequencies, pre- and post-treatment,
between the groups of smokers (29%) and
non-smokers (31%) was not significant
(Table 3).
Discussion
Helicobacter pylori is a carcinogen in humans,
although it is not thought to cause gastric
cancer directly. It may, however, provide a
suitable environment, by causing chronic
gastritis and intestinal metaplasia, for
neoplastic changes. H. pylori infection leads
to changes in many factors, such as the
vitamin C content of gastric juice, the levels
of reactive oxygen metabolites in the tissues
and epithelial cell proliferation, that are
important in the pathogenesis of gastric
cancer. Eradication of H. pylori may therefore
help prevent gastric cancer.5
Sister chromatid exchanges are seen in
most normal mammalian eukaryotic cells,
including those of humans. The number of
SCEs in normal human cells varies between
different cell groups, ranging from 2 to 20
with a mean frequency of 5 – 8.9 SCE analysis
is a sensitive index of the damage and repair
processes of DNA, and there is an elevated
frequency of SCE in cells exposed to various
mutagens and carcinogens in vitro. Elevated
frequencies of SCE in bone marrow cells and
peripheral blood lymphocytes of patients
with leukaemia, breast cancer and lung
cancer have also been reported.10 These
findings have provoked much interest in the
TABLE 3: 
Comparison of the percentage variation in the sister chromatid exchange (SCE)
frequencies before and after Helicobacter pylori eradication treatment with omeprazole,
clarithromycin and amoxycillin between the smoker and non-smoker subgroups
Variation in SCE frequencies (%) 
Smokers (n = 7) Non-smokers (n = 10)  
Mean SD Median Mean SD Median P-value  
–0.29 0.29 –0.39 –0.31 0.21 –0.32 > 0.05 
TABLE 2: 
Comparison of the pre- and post-treatment sister chromatid exchange (SCE) frequencies
in all patients receiving Helicobacter pylori eradication therapy with omeprazole,
clarithromycin and amoxycillin, and the smoker and non-smoker subgroups
SCE frequency 
Pre-treatment Post-treatment  
Group Mean SD Median Mean SD Median P-value  
All patients
(n =17) 8.94 2.01 9.56 5.84 1.52 5.60 < 0.01 
Smokers 
(n = 7) 9.19 2.53 10.16 6.06 6.08 1.82 < 0.05 
Non-smokers
(n = 10) 8.59 1.51 8.10 5.68 5.54 1.34 < 0.01
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relationship between SCE and a pre-
disposition to cancer or cancer status.11 This
study has shown that SCE frequency was
reduced significantly after triple therapy with
omeprazole, clarithromycin and amoxycillin.
A study in China reported significant
differences in the SCE frequencies between a
group of gastric cancer patients and a
control group, and between a group of
patients with chronic atrophic gastritis and a
control group.12
The frequency of SCE can also vary in
relation to a large number of factors such as
age, sex, genetics and environmental factors,
including smoking, alcohol intake,
radiation, chemical exposure and culture
conditions during sample preparation.11
Cigarette-smoke condensates produce many
dose-related lesions in the cellular DNA of
cultured human lymphocytes as measured
by SCE induction.13 This investigation found
that smoking in females and increasing age
in males appear to reduce the efficacy of
eradication treatment. Recent evidence from
both in vivo and in vitro studies strongly
suggests that oestrogens are epigenotoxic
carcinogens. They do not act as mutagenic
or DNA-damaging agents directly, but cause
inhereditable changes by an unknown
alternative mechanism. Progesterone also
has similar effects, causing excess
chromosomal gaps and breaks, and a
synergistic effect is seen with progesterone,
oestrogen and human chorionic
gonadotrophin. Both prolactin and follicle-
stimulating hormone produce excess
chromosomal gaps and breaks. These reports
clearly demonstrate that a variety of female
hormones may play a role in modifying or
enhancing DNA damage.14
In this small study, the genotoxic effects of
H. pylori prior to and following eradication
therapy were analysed with SCE frequency
analysis, a cytogenetic method. SCE
frequency was found to be reduced
significantly after eradication therapy in 
a group of gastritis patients infected with 
H. pylori. Age in males and smoking in
females may be risk factors that 
decrease effectiveness of the treatment.
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